Site search
2880 results for '' found
A Phase 1, Open-Label, Multicenter Study of INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms (NCT05936359)
A Phase 1, Open-Label, Multicenter Study of INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms (NCT05936359)
/
Comparing speech pathology and amitriptyline to speech pathology and placebo for the management of vocal cord dysfunction: a randomised controlled trial (ACTRN12619000158167)
Comparing speech pathology and amitriptyline to speech pathology and placebo for the management of vocal cord dysfunction: a randomised controlled trial (ACTRN12619000158167)
/
https://app.prompt.org.au/download/253190?code=bf75f8cc-636e-4810-afcc-8ced5fffb360
Life in the Alfred ICU
Most people who pass by The Alfred’s ICU building are unaware of what happens inside – but anyone who has entered its doors as a staff member, a patient or a loved one, will have a compelling story to tell.
/news/the-many-faces-of-the-alfreds-icu
World-first trial takes aim at deadly silicosis
New hope is on the horizon for silicosis sufferers with Melbourne experts set to embark on a world-first trial designed to halt progression of the deadly lung disease.
/news/world-first-trial-takes-aim-at-deadly-silicosis
Alfred_Health_GP_News_-_August_2025.pdf
Vic’s road to transplant
As 54 year old Vic Wiggins waited for a lifesaving heart transplant, he never gave up hope he’d one day be able to join his son on a long bike ride.
/news/vics-road-to-transplant
Ryan Smith
/about/bio/ryan-smith
Katherine Le
Katherine's longstanding interest in oncology has guided her academic and professional pursuits. Over the course of more than seven years, Katherine has developed extensive experience in administrative roles, demonstrating a strong capacity for organization and management within scientific and technical environments.
/about/bio/katherine-le